OSCR NYSE
Oscar Health, Inc.
1W: +4.5%
1M: +2.0%
3M: -1.6%
YTD: +106.7%
1Y: +63.7%
3Y: +466.7%
5Y: +82.2%
$30.94
+1.04 (+3.48%)
Weekly Expected Move ±6.0%
$27
$29
$31
$33
$35
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships9
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-01-28
Earliest Filing
2025-09-15
Latest Filing
investor: 9
Counterparties (Filed by OSCR)
9 relationshipsCompanies named in OSCR's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Dragoneer Investment Group, LLC | — | investor | Investment firm affiliated with purchasers in the Investment Agreement | 2025-09-15 | View |
| Dragoneer Investment Group, LLC | — | investor | Purchaser of $305M in 7.25% Convertible Senior Notes due 2031 | 2022-02-04 | View |
| Thrive Capital Management, LLC | — | investor | Purchaser of $305M in 7.25% Convertible Senior Notes due 2031 | 2022-02-04 | View |
| LionTree Investment Management, LLC | — | investor | Purchaser of $305M in 7.25% Convertible Senior Notes due 2031 | 2022-02-04 | View |
| Tenere Capital LLC | — | investor | Purchaser of $305M in 7.25% Convertible Senior Notes due 2031 | 2022-02-04 | View |
| Dragoneer Investment Group, LLC | — | investor | Investor in the issuance of 7.25% Convertible Senior Notes due 2031 | 2022-01-28 | View |
| Thrive Capital Management, LLC | — | investor | Investor in the issuance of 7.25% Convertible Senior Notes due 2031 | 2022-01-28 | View |
| LionTree Investment Management, LLC | — | investor | Investor in the issuance of 7.25% Convertible Senior Notes due 2031 | 2022-01-28 | View |
| Tenere Capital LLC | — | investor | Investor in the issuance of 7.25% Convertible Senior Notes due 2031 | 2022-01-28 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-16 | Regulation FD | View | |
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-06-09 | Shareholder Vote | View | |
| 2026-06-08 | Regulation FD | View | |
| 2026-06-02 | Officer/Director Change | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-04-21 | Regulation FD; Exhibits | View | |
| 2026-03-02 | Regulation FD Disclosure | View | |
| 2026-02-10 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of | Agreement | View |
| 2025-12-29 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-09-18 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-09-16 | Termination of Material Definitive Agreement; Other Events; Financial Statements and Exhibits | View | |
| 2025-09-15 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Other Events; Financial Statemen | Agreement | View |
| 2025-09-03 | Regulation FD Disclosure | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-22 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-06 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-03 | Regulation FD Disclosure | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR